PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $76,602 | -60.8% | 116,416 | -43.9% | 0.00% | – |
Q2 2023 | $195,285 | +68421.1% | 207,463 | -30.4% | 0.00% | – |
Q1 2023 | $285 | -57.8% | 298,090 | -39.1% | 0.00% | – |
Q4 2022 | $676 | -99.9% | 489,501 | -14.3% | 0.00% | – |
Q3 2022 | $714,000 | -20.0% | 571,242 | +51.0% | 0.00% | -100.0% |
Q2 2022 | $893,000 | +69.8% | 378,354 | +123.2% | 0.00% | – |
Q1 2022 | $526,000 | -59.5% | 169,517 | -17.2% | 0.00% | -100.0% |
Q4 2021 | $1,300,000 | -62.1% | 204,654 | -40.5% | 0.00% | -50.0% |
Q3 2021 | $3,428,000 | +32.7% | 344,178 | +76.3% | 0.00% | 0.0% |
Q2 2021 | $2,584,000 | -6.1% | 195,196 | +81.4% | 0.00% | 0.0% |
Q4 2020 | $2,751,000 | +267.8% | 107,579 | +88.4% | 0.00% | +100.0% |
Q3 2020 | $748,000 | -71.0% | 57,089 | -65.2% | 0.00% | -83.3% |
Q1 2020 | $2,581,000 | – | 163,853 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
Annandale Capital, LLC | 54,338 | $51 | 0.02% |